George T Tsangaris
Overview
Explore the profile of George T Tsangaris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petre M, Kontouli Pertesi A, Boulioglou O, Sarantidi E, Korovesi A, Kozei A, et al.
Foods
. 2024 Dec;
13(23).
PMID: 39683021
Colostrum is essential for the survival and development of newborn mammals. This primary source of nourishment during the first days of infant life is rich in functional components conductive to...
2.
Bouroutzika E, Proikakis S, Theodosiadou E, Vougas K, Katsafadou A, Tsangaris G, et al.
Animals (Basel)
. 2024 Feb;
14(3).
PMID: 38338042
Melatonin is an indoleamine with broad spectrum properties that acts as a regulator of antioxidant and immune response in organisms. In our previous studies, melatonin improved redox status and inflammatory...
3.
Kattan F, Koukouraki P, Anagnostopoulos A, Tsangaris G, Doxakis E
Open Biol
. 2023 Nov;
13(11):230158.
PMID: 37989221
Alpha-synuclein (SNCA) accumulation plays a central role in the pathogenesis of Parkinson's disease. Determining and interfering with the mechanisms that control SNCA expression is one approach to limiting disease progression....
4.
Kontopodis E, Pierros V, Stravopodis D, Tsangaris G
Vaccines (Basel)
. 2022 Mar;
10(3).
PMID: 35334990
The recently discovered Omicron variant of the SARS-CoV-2 coronavirus has raised a new, global, awareness. In this study, we identified the Core Unique Peptides (CrUPs) that reside exclusively in the...
5.
Zografos E, Proikakis S, Anagnostopoulos A, Korakiti A, Zagouri F, Gazouli M, et al.
Cancer Genomics Proteomics
. 2022 Feb;
19(2):229-240.
PMID: 35181590
Background/aim: Until now, little emphasis has been placed on the protein expression profile of male breast cancer (MBC) tumors, due to the rarity of the disease. The present study aimed...
6.
Karouzaki S, Peta C, Tsirimonaki E, Leondaritis G, Vougas K, Tsangaris G, et al.
Int J Dev Biol
. 2021 Dec;
66(1-2-3):187-197.
PMID: 34881797
Embryonic stem cells, ESCs, retain the capacity to self-renew, yet, the protein machinery essential in maintaining this undifferentiated status remains largely undefined. Signalling interactions are initiated and enhanced at the...
7.
Anagnostopoulos A, Vougas K, Kolialexi A, Mavrou A, Fountoulakis M, Tsangaris G
Cancer Genomics Proteomics
. 2019 Aug;
2(5):271-299.
PMID: 31394625
The human immature T-cell line CCRF-CEM is widely used for all kinds of in vitro studies in biochemistry, biology, toxicology and medicine. Knowledge about protein expression is limited and no...
8.
Zografos E, Anagnostopoulos A, Papadopoulou A, Legaki E, Zagouri F, Marinos E, et al.
Cancer Genomics Proteomics
. 2019 Mar;
16(2):129-137.
PMID: 30850364
Background: To date, the elucidation of serum protein alterations in male breast cancer (MBC) has not been extensively studied, due to the rarity of the disease. Materials And Methods: In...
9.
Tsigaridas A, Anagnostopoulos A, Papadopoulou A, Ioakeim S, Vaiopoulou A, Papanikolaou I, et al.
J Proteomics
. 2017 Aug;
188:167-172.
PMID: 28757466
Significance: Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder with high incidence and great heterogeneity of symptoms without any appropriate diagnostic tool available. Eight significantly different expressed proteins were...
10.
Tsangaris G, Dimas K, Malamou A, Katsafadou A, Papathanasiou C, Stravopodis D, et al.
Cancer Genomics Proteomics
. 2017 Jun;
14(4):267-275.
PMID: 28647700
Background/aim: Medulloblastoma (MBL), an archetypal primitive neuroectodermal tumor of the cerebellum, is the most common pediatric central nervous system malignancy representing approximately 20% of all childhood brain tumors. Herein, we...